Predictions
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€121.28
23.10.21
23.10.21
€130.00
23.10.22
23.10.22
3.61%
05.11.21
05.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€121.28
23.10.21
23.10.21
€130.00
23.10.22
23.10.22
3.61%
05.11.21
05.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
Intel Corp.
Start price
Target price
Perf. (%)
€43.31
22.10.21
22.10.21
-
22.10.24
22.10.24
6.21%
28.12.21
28.12.21
Could be worthwhile Investment >10% per year
Intel Corp.
Start price
Target price
Perf. (%)
€43.31
22.10.21
22.10.21
-
22.10.24
22.10.24
6.21%
28.12.21
28.12.21
Could be worthwhile Investment >10% per year
Intel Corp.
Start price
Target price
Perf. (%)
€43.31
22.10.21
22.10.21
-
22.10.24
22.10.24
6.21%
28.12.21
28.12.21
Could be worthwhile Investment >10% per year
Intel Corp.
Start price
Target price
Perf. (%)
€43.31
22.10.21
22.10.21
-
22.10.24
22.10.24
6.21%
28.12.21
28.12.21
Could be worthwhile Investment >10% per year
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€39.83
20.10.21
20.10.21
€15.00
31.12.23
31.12.23
-28.06%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Humana Inc.
Start price
Target price
Perf. (%)
€390.10
20.10.21
20.10.21
€460.00
31.12.23
31.12.23
25.56%
01.09.22
01.09.22
Could be very worthwhile Investment >20% year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€373.45
20.10.21
20.10.21
€450.00
31.12.23
31.12.23
28.49%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€373.45
20.10.21
20.10.21
€450.00
31.12.23
31.12.23
28.49%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
CVS Health Corp.
Start price
Target price
Perf. (%)
€74.28
20.10.21
20.10.21
€90.00
31.12.23
31.12.23
19.82%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€117.42
20.10.21
20.10.21
€105.00
20.10.22
20.10.22
24.32%
11.11.21
11.11.21
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Anthem Inc.
Start price
Target price
Perf. (%)
€363.90
20.10.21
20.10.21
€400.00
31.12.23
31.12.23
26.90%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€2.83
20.10.21
20.10.21
€5.00
31.12.23
31.12.23
-62.30%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Applied Genetic Technologies Corp.
Start price
Target price
Perf. (%)
€2.28
20.10.21
20.10.21
€5.00
31.12.23
31.12.23
-84.94%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year